account_id none on file
legal_name Perspective Therapeutics, Inc.
ticker CATX
cik 728387
domain perspectivetherapeutics.com
linkedin_company_url https://www.linkedin.com/company/perspective-therapeutics
entry_point_account_id none on file
name Perspective Therapeutics Inc.
exchange NYSE
sector Health Care
hq Seattle, WA, United States
sector index/company/sector/health-care/
calls 0 filings 4 executives 10 family 0
why_nownone on file
callsnone on file
filings
is raised through either additional public or private equity financings, debt financings, strategic relationships, alliances and licensing agreements, or a combination thereof, we may delay, limit or reduce discretionary spending in areas related to research and development activities and other general and administrative expenses in order to fund our operating costs and working capital needs.
filing / Aug 10, 2026 / receipt
On July 1, 2023, the Company entered into a lease for office space in Seattle, WA, that terminates in October 2028. Upon entering into this lease, the Company recognized a right-of-use asset and lease liability of approximately $ 0.8 million in the Condensed Consolidated Balance Sheet based upon the present value of the future lease payments discounted at an 8 % discount rate using the rate of interest that the Compa
filing / Aug 10, 2026 / receipt
is raised through either additional public or private equity financings, debt financings, strategic relationships, alliances and licensing agreements, or a combination thereof, we may delay, limit or reduce discretionary spending in areas related to research and development activities and other general and administrative expenses in order to fund our operating costs and working capital needs.
filing / May 11, 2026 / receipt
On July 1, 2023, the Company entered into a lease for office space in Seattle, WA, that terminates in October 2028. Upon entering into this lease, the Company recognized a right-of-use asset and lease liability of approximately $ 0.8 million in the Condensed Consolidated Balance Sheet based upon the present value of the future lease payments discounted at an 8 % discount rate using the rate of interest that the Compa
filing / May 11, 2026 / receipt
executives
| Dwight Babcock | Chairman of the Board | - | receipt |
| Heidi Henson | director | - | receipt |
| Jennifer Streeter | Interim Chief Operating Officer | - | receipt |
| Joel Sendek | Chief Financial Officer | receipt | |
| Jonathan Hunt | Chief Financial Officer | - | receipt |
| Juan Graham | Chief Financial Officer | - | receipt |
| Lori Woods | Vice President | - | receipt |
| Matthew Branson | Principal Financial Officer | - | receipt |
| Michael McCormick | Chairman of the Board | - | receipt |
| Thomas LaVoy | Chairman of the Board | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changes
| 2025-09-04 | Chief Financial Officer, appointed | sec_8k |
| 2025-01-06 | Chief Financial Officer, appointed | sec_8k |
| 2023-05-15 | director, appointed | sec_8k |
| 2023-02-10 | Chief Research and Development Officer, departed | sec_8k |
| 2023-02-06 | Chief Executive Officer, departed | sec_8k |
| 2019-07-24 | Interim Chief Operating Officer, appointed | sec_8k |
| 2018-12-17 | Chief Executive Officer, appointed | sec_8k |
| 2018-12-03 | Chief Financial Officer, appointed | sec_8k |
| 2018-06-05 | Chairman of the Board, appointed | sec_8k |
| 2017-01-17 | Principal Financial Officer, appointed | sec_8k |
| 2016-01-15 | Chairman of the Board, appointed | sec_8k |
| 2016-01-12 | Chairman, appointed | sec_8k |
mcp_package_hint
slug perspective-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$